Read more

March 11, 2022
2 min watch
Save

VIDEO: Rhopressa increases episcleral venous blood flow

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Osamah Saeedi, MD, discusses results from a study exploring the effect of Rhopressa (netarsudil ophthalmic solution 0.02%, Aerie Pharmaceuticals) on episcleral venous flow rates.